Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan

Liu Y.Tang C.-H.Qiu H.Siggins S.HSIN-AN HOU2022-01-122022-01-1220212045-2322https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099348684&doi=10.1038%2fs41598-020-80607-4&partnerID=40&md5=dfb92ca35713d0f6852c273c9130853bhttps://scholars.lib.ntu.edu.tw/handle/123456789/592145[SDGs]SDG3Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwanjournal article10.1038/s41598-020-80607-4334419012-s2.0-85099348684